Document is current
Any future updates will be listed below
-
Authors
Yankova, Eliza https://orcid.org/0000-0003-2913-0012
Blackaby, Wesley
Albertella, Mark
Rak, Justyna
De Braekeleer, Etienne
Tsagkogeorga, Georgia
Pilka, Ewa S. https://orcid.org/0000-0002-0107-2597
Aspris, Demetrios
Leggate, Dan
Hendrick, Alan G. https://orcid.org/0000-0002-8604-0462
Webster, Natalie A.
Andrews, Byron
Fosbeary, Richard
Guest, Patrick
Irigoyen, Nerea https://orcid.org/0000-0001-6346-3369
Eleftheriou, Maria
Gozdecka, Malgorzata
Dias, Joao M. L. https://orcid.org/0000-0002-8451-3537
Bannister, Andrew J. https://orcid.org/0000-0002-6312-4436
Vick, Binje https://orcid.org/0000-0003-1956-2778
Jeremias, Irmela https://orcid.org/0000-0003-1773-7677
Vassiliou, George S. https://orcid.org/0000-0003-4337-8022
Rausch, Oliver https://orcid.org/0000-0003-4074-3848
Tzelepis, Konstantinos https://orcid.org/0000-0002-4865-7648
Kouzarides, Tony https://orcid.org/0000-0002-8918-4162
- License Information
-
More Information
Article History
Received: 18 December 2020
Accepted: 12 April 2021
First Online: 26 April 2021
Competing interests
: T.K. is a co-founder of Abcam Plc and Storm Therapeutics Ltd, Cambridge, UK and Scientific Advisor to Foghorn Therapeutics and EpiVario. E.Y. is funded by Storm Therapeutics Ltd, Cambridge, UK. W.B., M.A., G.T., D.L., B.A., R.F., A.G.H., N.A.W., P.G. and O.R. are employees of Storm Therapeutics Ltd, Cambridge, UK. E.S.P. is an employee of Evotec (UK) Ltd, Abingdon, UK. George S. Vassiliou is a consultant for Kymab, Cambridge, UK. Storm Therapeutics Ltd is the owner of a patent application (WO2020201773) covering the development of METTL3 RNA methyltrasferase inhibitors.
